BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36085376)

  • 1. The value of CT features and demographic data in the differential diagnosis of type 2 papillary renal cell carcinoma from fat-poor angiomyolipoma and oncocytoma.
    Zhou C; Ban X; Luo L; Shi C
    Abdom Radiol (NY); 2022 Nov; 47(11):3838-3846. PubMed ID: 36085376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of computed tomography features in the differential diagnosis of chromophobe renal cell carcinoma from oncocytoma and angiomyolipoma without visible fat.
    Zhou C; Ban X; Lv J; Cheng L; Xu J; Shen X
    Quant Imaging Med Surg; 2022 Apr; 12(4):2332-2343. PubMed ID: 35371954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT differentiation of fat-poor angiomyolipomas from papillary renal cell carcinomas: development of a predictive model.
    Salvador R; Sebastià M; Cárdenas G; Páez-Carpio A; Paño B; Solé M; Nicolau C
    Abdom Radiol (NY); 2021 Jul; 46(7):3280-3287. PubMed ID: 33674961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients.
    Kim YH; Han K; Oh YT; Jung DC; Cho NH; Park SY
    Abdom Radiol (NY); 2018 Mar; 43(3):647-654. PubMed ID: 28677004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiomyolipoma with minimal fat: differentiation from papillary renal cell carcinoma by helical CT.
    Zhang YY; Luo S; Liu Y; Xu RT
    Clin Radiol; 2013 Apr; 68(4):365-70. PubMed ID: 23321146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between papillary renal cell carcinoma and fat-poor angiomyolipoma: a preliminary study assessing detection of intratumoral hemorrhage with chemical shift MRI and T2*-weighted gradient echo.
    Woo S; Kim SY; Cho JY; Kim SH
    Acta Radiol; 2018 May; 59(5):627-634. PubMed ID: 29069911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
    Qu JY; Jiang H; Song XH; Wu JK; Ma H
    Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation.
    Matsumoto S; Arita Y; Yoshida S; Fukushima H; Kimura K; Yamada I; Tanaka H; Yagi F; Yokoyama M; Matsuoka Y; Oya M; Tateishi U; Jinzaki M; Fujii Y
    Abdom Radiol (NY); 2022 Jun; 47(6):2178-2186. PubMed ID: 35426498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.
    Varghese BA; Chen F; Hwang DH; Cen SY; Desai B; Gill IS; Duddalwar VA
    AJR Am J Roentgenol; 2018 Dec; 211(6):W288-W296. PubMed ID: 30240299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
    Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
    Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
    Kang HS; Park JJ
    Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study.
    Luo S; Lin W; Wu J; Zhang W; Kui X; Lai S; Wei R; Pang X; Wang Y; He C; Liu J; Yang R
    Acad Radiol; 2024 Apr; 31(4):1460-1471. PubMed ID: 37945492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.